NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

NCT03200626

CompletedN/A

Sponsor: Medical College of Wisconsin

Conditions: Multiple Myeloma, Bone Marrow Transplant Complications

Interventions: Autologous hematopoietic cell transplant

Countries: United States

Prospective, multicenter, observational registry of myeloma patients undergoing hematopoietic progenitor cell mobilization for upfront autologous transplantation.

Eligibility overview

Sex: ALL

Age: 18 Years to 70 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Myeloma patients ages 18-70 years.
* Undergoing upfront autoHCT (≤12 months from start of initial therapy for myeloma).

Exclusion Criteria:

* Patients with light chain (AL) amyloidosis or myeloma with associated AL amyloidosis.
* POEMS syndrome

Locations (1)

Milwaukee, Wisconsin, United States